The Physicians at the Johns Hopkins Kimmel Cancer Center have treated a small group of less than 20 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia. The physicians used a “partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug called ”. In order for the patients